Skip to content

Not medical advice. Talk to your provider before using any peptide. Full disclaimer

Peptide Schedule Research TeamReviewed Apr 7, 20268 Citations

Exenatide (Byetta / Bydureon) peptide icon, one bubble per amino acidExenatide (Byetta / Bydureon)39 residuesHGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPSEach bubble = one amino acid. Size = residue mass. Color = chemical class.

Exenatide (Byetta / Bydureon) Dosage Calculator

Weight Loss · FDA Approved · Grade A · 2.4 h half-life · Injection

Dosing protocol

Exenatide (Byetta / Bydureon) Dosage

LevelDose / InjectionFrequency
Beginner5 mcg2x Daily
Moderate10 mcg2x Daily
Aggressive2 mgWeekly

Cycle: No scheduled off period.

No syringe calculation for this route

Subcutaneous

Exenatide (Byetta / Bydureon) has no default water volume for this calculator, so there are no syringe units to calculate here. Dosing runs 5 mcg to 2000 mcg per administration, 2x daily.

If your product does arrive as a powder, use the universal reconstitution calculator and enter your own vial size and water volume.

Open Exenatide (Byetta / Bydureon) details
Side effects, protocols by goal, storage, and the sources behind these dosing numbers.

About Exenatide (Byetta / Bydureon)

Beginner, moderate, and aggressive dosing amounts with timing. Free to use.

Exenatide was the first FDA-approved GLP-1 receptor agonist for type 2 diabetes. Both Byetta (twice daily) and Bydureon (weekly) were discontinued in October 2024. Complete clinical data, side effect profile, and transition guidance covered here. A generic exenatide injection (ANDA 206697) has been FDA-approved since November 2024.

GLP-1 AgonistType 2 DiabetesBlood Sugar ControlWeight ManagementFDA-Approved
Subcutaneous. Typical beginner frequency: 2x daily.
Store at 2-8°C (36-46°F) until first use. Pre-filled pens: refrigerate at 2-8°C before first use.

View side effects and safety warnings →

Quick-Start: How to Use Exenatide (Byetta / Bydureon)

  1. 1Check the pen. Byetta pens should contain clear, colorless solution. Bydureon suspension will look cloudy after mixing. Discard if you see particles, discoloration, or the expiration date has passed.
  2. 2Choose your injection site: abdomen, upper thigh, or back of the upper arm. Rotate sites each injection. Clean the area with an alcohol swab and let it dry.
  3. 3Attach a new pen needle. For Byetta, a 31-gauge, 6mm or 8mm needle works well. Remove both the outer and inner needle caps.
Full usage guide →

Exenatide (Byetta / Bydureon) Dosing Protocol

FDA LabelByetta (exenatide) FDA Prescribing Information (2014)
LevelDose / InjectionFrequency
Beginner5 mcg2x Daily
Moderate10 mcg2x Daily
Aggressive2 mgWeekly
Note:

Both Byetta and Bydureon BCise were permanently discontinued in October 2024. Drugs@FDA lists a generic exenatide injection from Amneal (ANDA 206697, approved November 19, 2024) as an active prescription product. If you still have pens from before the discontinuation, check the expiration date and don't use anything past it.

Byetta came as pre-filled pens. No reconstitution needed. The 5 mcg pen delivered 60 doses (one month at twice daily); the 10 mcg pen also delivered 60 doses. No bacteriostatic water, no insulin syringes, no mixing. Refrigerate before first use; after that, room temperature up to 30 degrees C for 30 days.

Bydureon required reconstituting a microsphere suspension immediately before injection. It came in single-dose kits. The BCise autoinjector simplified this, but neither can be replicated by a compounding pharmacy.

The biggest mistake most beginners made was timing. Inject within 60 minutes before the meal, not after. If you took it after eating, nausea got worse and glucose control suffered. Keep the two daily doses at least 6 hours apart.

If you're on oral medications like antibiotics or birth control pills, take those at least one hour before your exenatide injection. The gastric emptying delay will slow their absorption otherwise. For anyone currently searching for exenatide: transition to semaglutide or tirzepatide with prescriber guidance.

Dosing based on Byetta (exenatide) FDA Prescribing Information (2014): 8 published references.View all sources →

Ask AI about this math

Cross-check your Exenatide (Byetta / Bydureon) reconstitution math with AI

Exenatide (Byetta / Bydureon) Cost

Brand Price
Byetta: ~$956 retail (pre-discontinuation); typical US cash price with coupon ~$521 (2026 residual inventory may exist at some pharmacies)
Generic / Research
Generic exenatide injection: Amneal, ANDA 206697, FDA-approved November 19, 2024 (Drugs@FDA lists it as a prescription product). No price on file.
Compounded
No widely available compounded exenatide. Bydureon microsphere technology is not reproducible by standard compounding pharmacies. Research-grade lyophilized exenatide is sold on the grey market (quality unverified).

Pricing updated 2026-04-09

Prices are estimates and vary by source, location, and prescription status.Full pricing breakdown →

Exenatide (Byetta / Bydureon) Pharmacokinetics

Pharmacokinetics: Active Dose Over Time

t½ = ~2.4 hours (Byetta IR); ~2 weeks sustained release (Bydureon ER)
50%25%12.5%100%75%50%25%0%02h5h7h10h12hTime after injectionDose remaining
After 1 half-life (2h): 50% remainsAfter 2 half-lives (5h): 25% remainsAfter 3 half-lives (7h): 12.5% remains
At a 10 mcg dose: 50% = 5 mcg remaining after 2h. Moderate-tier frequency in our sources: 2x Daily.

Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only, not medical advice.

Read the full Exenatide (Byetta / Bydureon) guide →

Related Tools

Frequently Asked Questions

Store Exenatide (Byetta / Bydureon) at 2-8°C (36-46°F) until first use. Pre-filled pens: refrigerate at 2-8°C before first use.

Byetta: start at 5 mcg subcutaneous twice daily (within 60 minutes before meals); increase to 10 mcg twice daily after 1 month. Bydureon: 2 mg (2,000 mcg) subcutaneous once weekly. The extended-release formulation is preferred for adherence since it eliminates the meal-timing requirement.